Ming-Feng Hou Selected Research

Matrix Metalloproteinases (MMPs)

7/2013	Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathway.
1/2012	In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrate.
8/2009	Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Feng Hou Research Topics

Disease

162	Breast Neoplasms (Breast Cancer) 05/2024 - 07/2002
141	Neoplasms (Cancer) 05/2024 - 02/2002
35	Neoplasm Metastasis (Metastasis) 05/2024 - 01/2003
18	Triple Negative Breast Neoplasms 05/2024 - 01/2014
16	Carcinogenesis 01/2024 - 11/2005
9	Lymphatic Metastasis 01/2019 - 06/2006
7	Carcinoma (Carcinomatosis) 09/2022 - 10/2011
6	Mouth Neoplasms (Oral Cancer) 10/2022 - 08/2019
6	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 07/2002
5	Inflammation (Inflammations) 09/2017 - 01/2004
4	Pain (Aches) 04/2021 - 11/2012
4	Stomach Neoplasms (Stomach Cancer) 03/2015 - 05/2003
4	Melanoma (Melanoma, Malignant) 11/2013 - 06/2004
3	Infections 08/2022 - 01/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 06/2004
3	Dermatitis 01/2015 - 10/2006
3	Squamous Cell Carcinoma of Head and Neck 02/2013 - 02/2012
2	Diabetes Mellitus 08/2022 - 12/2014
2	Disease Progression 01/2020 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 06/2014

Drug/Important Bio-Agent (IBA)

29	Estrogen ReceptorsIBA 09/2022 - 05/2006
24	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2006
23	Biomarkers (Surrogate Marker)IBA 01/2024 - 04/2009
21	Hormones (Hormone)IBA 04/2024 - 05/2006
11	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 11/2005
10	EnzymesIBA 03/2023 - 01/2003
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 06/2006
8	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2013
7	AdipokinesIBA 01/2022 - 06/2006
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2012
6	Cadherins (E-Cadherin)IBA 05/2024 - 05/2006
6	Messenger RNA (mRNA)IBA 05/2023 - 01/2006
6	AntioxidantsIBA 12/2022 - 11/2005
6	Phosphotransferases (Kinase)IBA 05/2022 - 06/2006
6	Tamoxifen FDA LinkGeneric 01/2020 - 11/2002
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2011
6	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 02/2002
6	FlavonoidsIBA 02/2016 - 12/2010
5	CytokinesIBA 07/2023 - 11/2011
5	LipidsIBA 06/2023 - 01/2007
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2023 - 09/2012
5	Superoxides (Superoxide)IBA 05/2022 - 01/2004
5	Conditioned Culture MediaIBA 01/2022 - 06/2014
5	phthalic acid (phthalate)IBA 01/2022 - 08/2012
5	Nicotinamide PhosphoribosyltransferaseIBA 11/2020 - 09/2011
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2014 - 04/2008
4	Epidermal Growth Factor (EGF)IBA 03/2023 - 12/2011
4	Annexin A5IBA 09/2022 - 06/2013
4	CaspasesIBA 09/2022 - 02/2016
4	Acetylcysteine (Siran)FDA LinkGeneric 07/2022 - 02/2016
4	LigandsIBA 01/2022 - 01/2014
4	IntegrinsIBA 12/2019 - 02/2013
4	Tumor Biomarkers (Tumor Markers)IBA 04/2016 - 11/2009
4	Estrogens (Estrogen)FDA Link 10/2014 - 11/2002
3	Glutathione (Reduced Glutathione)IBA 12/2022 - 11/2006
3	fucoidanIBA 09/2022 - 04/2022
3	ORALIT (ORS)IBA 09/2022 - 09/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2015
3	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2021 - 02/2011
3	Ligases (Synthetase)IBA 09/2021 - 09/2009
3	UbiquitinIBA 09/2021 - 09/2009
3	Phenobarbital (Luminal)FDA Link 01/2021 - 08/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2019
3	Metalloproteases (Metalloproteinases)IBA 11/2018 - 08/2009
3	human ERBB2 proteinIBA 01/2018 - 07/2006
3	CateninsIBA 01/2018 - 04/2013
3	AgarIBA 01/2017 - 06/2013
3	InterleukinsIBA 03/2015 - 06/2013
3	Interleukin-8 (Interleukin 8)IBA 03/2015 - 06/2013
3	CC ChemokinesIBA 02/2015 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 04/2009
3	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 08/2009
3	CalciumIBA 06/2013 - 01/2011
3	Codon (Codons)IBA 05/2013 - 05/2003
3	Nuclear Proteins (Protein, Nuclear)IBA 09/2012 - 01/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 10/2017
2	Sirolimus (Rapamycin)FDA Link 05/2022 - 02/2015
2	ResistinIBA 01/2022 - 06/2012
2	Monoclonal AntibodiesIBA 01/2022 - 01/2013
2	Diethylhexyl Phthalate (DEHP)IBA 01/2022 - 02/2016
2	mono-(2-ethylhexyl)phthalateIBA 01/2022 - 11/2018
2	2-methyl-5,6-cyclopentapyrimidineIBA 01/2022 - 11/2018
2	CreatinineIBA 01/2022 - 01/2003
2	ChemokinesIBA 01/2022 - 03/2015
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 12/2019
2	LuciferasesIBA 11/2020 - 06/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 06/2013

Therapy/Procedure

40	Therapeutics 01/2024 - 01/2003
16	Drug Therapy (Chemotherapy) 01/2022 - 09/2006
15	Radiotherapy 05/2024 - 09/2006
6	Mastectomy (Mammectomy) 05/2024 - 09/2002
4	Segmental Mastectomy (Lumpectomy) 05/2024 - 10/2015
4	Precision Medicine 12/2023 - 03/2023
4	Adjuvant Chemotherapy 06/2018 - 03/2008
3	Immunotherapy 07/2023 - 06/2014
3	Mammaplasty (Breast Reconstruction) 12/2019 - 08/2002
3	Modified Radical Mastectomy (Mastectomy, Modified) 01/2016 - 08/2012
2	Neoadjuvant Therapy 12/2022 - 03/2022
2	Chemoradiotherapy 03/2022 - 07/2021
2	Myocutaneous Flap 01/2020 - 09/2014